Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
about
Vitamin D supplementation for prevention of cancer in adultsVitamin D supplementation for prevention of mortality in adultsVitamin D supplementation for prevention of mortality in adultsCalcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical reviewThe relationship between nutrition and prostate cancer: is more always better?How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causalityNucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer TherapyVitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological EvidenceVitamin D and Immune Response: Implications for Prostate Cancer in African AmericansCirculating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Vitamin D: The "sunshine" vitaminPretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series studyVitamin D: newly discovered actions require reconsideration of physiologic requirements.The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth controlPlasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort.The impact of delayed blood centrifuging, choice of collection tube, and type of assay on 25-hydroxyvitamin D concentrations1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer.The human health effects of ozone depletion and interactions with climate change.Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialProstate cancer and the influence of dietary factors and supplements: a systematic review.Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis.Vitamin D deficiency predicts prostate biopsy outcomes.Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and womenIndoor ultraviolet tanning and skin cancer: health risks and opportunities.Apc(MIN) modulation of vitamin D secosteroid growth controlMeta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines.Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research.Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trialHow to reduce your cancer risk: mechanisms and myths.Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening TrialPlasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany studyInverse association between dietary vitamin D and risk of cutaneous melanoma in a northern Italy population.Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.Vitamin d, sunlight and prostate cancer riskVitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells
P2860
Q24193850-636601F0-832F-48B3-898B-4EF62C41596CQ24201160-8F1817F0-7EED-4B62-BDEB-64A90016A1E0Q24235390-964A01F9-6F6F-428B-8139-204058BECEB7Q24597422-EECF26E0-E0C3-4DE1-9719-CB30F5E71C88Q24604956-516F9A4C-7EAA-49FE-8DE1-50673276A50DQ24645200-79C65F6B-7F24-4806-91C0-D3D37326CCCBQ26750627-571D13D5-19F1-4303-8554-1EFD08288DADQ26766256-CF1B93E3-4385-4269-A42B-1AFFBE5AB518Q26768536-FE35A070-1527-4083-A029-E0335D720016Q27336054-9904A49A-9764-480A-99C3-6EF800F2FB74Q30417236-31963805-AA46-4CC7-AA95-A4982D32CC8AQ31001849-C5FBA2EF-3604-4DBE-B76B-01894CABAB92Q33530770-C9A2D15C-5C43-4062-94A9-03C83E296CD1Q33670411-2B5B4540-4E03-447F-94AB-4F03707A5B30Q33712468-45AF8E34-BD4A-49B5-A9A1-78312AA50B13Q33768535-CFBA750A-FBCF-4C8E-A9F6-C4D679E0C7B5Q33772417-94A988FF-4ED6-4D42-9084-30D089F2D62CQ33783979-A8B54BD5-1591-43DE-9398-E390F88514C2Q33799335-F6C98DAA-2095-4EF5-83EE-0BD634422B24Q33803855-4B46F8CF-AEA7-447D-8C99-950EFCB5E317Q33813910-352EC362-A2CA-421E-8FD1-F21CECBE607BQ33864647-056228F1-27C8-4676-98E7-8EC808A87B43Q33923335-3AF43923-67AD-4BFA-A009-564001B7C92CQ33992150-DF9532C3-14E1-4819-B1FE-1F39E438BDEAQ34005530-7EC8571C-A7CD-4270-AFDE-BAE3943E778BQ34018094-F58BE8AB-B0DF-4E1C-A192-F2513B5B47E2Q34042325-628534C9-C512-4430-8D37-57008054F4D3Q34115732-AFBC44F7-00B4-4902-8B90-AF0A7E86B1F1Q34235424-79A9A531-BD8C-47C3-983C-F0D5EDBCA662Q34281077-32696028-9204-403F-8443-78B2282D09D4Q34284547-6B464CFD-DDCF-4709-A40D-0D89EB6B5DFBQ34397763-47E3E088-2B06-4164-B704-EB3F69D075DCQ34639440-DA06EB50-164E-4292-8C83-9C4E5DDB31D3Q34894797-C3FB4D14-0106-459D-AD5F-3703FE59CD57Q34898979-50F08195-BD31-4827-A022-3E93362EE05DQ34919132-FE874440-9272-4143-9E01-01A4AF525FBDQ34995493-30C40CF4-D126-4E71-BA12-AC05A0DD69C3Q35036628-FC5408C5-9AE6-444B-BF66-3E47FBAA2878Q35207472-4C52CDB5-7545-4E0D-A0D1-9326FA05A98DQ35238349-87D1B04F-6948-498F-91E3-8AC5F25CDD31
P2860
Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
@en
type
label
Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
@en
prefLabel
Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
@en
P2093
P2860
P50
P356
P1476
Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
@en
P2093
Bruce W Hollis
James M Shikany
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team
Ronald L Horst
Ulrike Peters
Wen-Yi Huang
P2860
P304
P356
10.1093/JNCI/DJN152
P407
P577
2008-05-27T00:00:00Z